Breaking into bone biology: serotonin's secrets

@article{Rosen2009BreakingIB,
  title={Breaking into bone biology: serotonin's secrets},
  author={Clifford J. Rosen},
  journal={Nature Medicine},
  year={2009},
  volume={15},
  pages={145-146}
}
  • C. Rosen
  • Published 1 February 2009
  • Biology
  • Nature Medicine
Extracellular Vesicles from Child Gut Microbiota Enter into Bone to Preserve Bone Mass and Strength
TLDR
The study identifies that gut bacterium Akk mediates the CGM‐induced anti‐osteoporotic effects and presents a novel mechanism underlying the exchange of signals between GM and host bone.
Serotonin
Structure Determination of Serotonin using Quantum Approximations
ARTICLE INFO The role played by computational quantum theory methods especially HartreeFock (HF) and Density functional theory (DFT) in physical chemistry and theoretical physics is very important
The Impact of the Serotonin on the Cause and Treatment of Cancer
This review article goes through many researches based on the effectiveness of the neurotransmitter serotonin on cancer cells and also the impact of SSRIs (selective serotonin reuptake inhibitors)
5 Fatty Acids and Emotional Behavior
TLDR
Interestingly, fatty acids are present in amniotic fluid, colostrum, and maternal milk in at least two mammalian species and according to both anecdotal and experimental reports appear to produce anxiolytic effects.
Prebiotics and Bone.
TLDR
The dynamic role of prebiotics in bone health is discussed by discussing the current state of the art, addressing gaps in knowledge and their role in public health.
Transcriptome sequencing and differential gene expression analysis of the schistosome-transmitting snail Oncomelania hupensis inhabiting hilly and marshland regions
TLDR
Analysis of expression changes between environments showed that upregulated genes relating to immunity and development were enriched in hilly snails, while those associated with reproduction were over-represented in marshland snails.
Peripheral serotonin-mediated system suppresses bone development and regeneration via serotonin 6 G-protein-coupled receptor
TLDR
Findings indicate a key role of 5-HT6R in bone formation through serotonin originating in the peripheral system, and suggest that it is a novel therapeutic target for drug development in the bone repair and bone diseases.
Increased endogenous serotonin level in diabetic conditions may lead to cardiac valvulopathy via reactive oxygen species regulation
TLDR
It is suggested that endogenous enhanced serotonin level may contribute as a bridge between diabetes and cardiovascular diseases via acceleration of free radical generation in diabetic conditions through reactive oxygen species (ROS) generation.
...
1
2
3
...

References

SHOWING 1-10 OF 13 REFERENCES
Bacterial Heat-Stable Enterotoxins: Translation of Pathogenic Peptides into Novel Targeted Diagnostics and Therapeutics
TLDR
The physiological and pathophysiological role of GC-C in fluid-electrolyte regulation and intestinal crypt-villus homeostasis is summarized and translational opportunities offered by STs are described, reflecting the unique characteristics ofGC-C, in treating irritable bowel syndrome and chronic constipation, and in preventing and treating colorectal cancer.
Serotonin (5-hydroxytryptamine) transporter inhibition causes bone loss in adult mice independently of estrogen deficiency
TLDR
The data indicate that a commonly prescribed SSRI has a negative influence on the adult skeleton, independent of estrogen deficiency, which supports clinical data demonstrating SSRI use to be associated with accelerated bone loss after menopause and highlights a need for further research into the skeletal effects of SSRIs.
Skeletal effects of serotonin (5-hydroxytryptamine) transporter inhibition: evidence from clinical studies.
TLDR
Questions about how depression, antidepressant therapy and SSRIs impact bone health in humans are reviewed, to better understand how these factors interact to influence skeletal status and to characterize the biochemical mechanism through which 5-HT may mediate bone turnover and metabolism.
Skeletal effects of serotonin (5-hydroxytryptamine) transporter inhibition: evidence from in vitro and animal-based studies.
TLDR
The preclinical evidence for the skeletal effects of 5-HT and the inhibition of the5-HTT is discussed, which includes in vitro and in vivo skeletal effects from the selective serotonin reuptake inhibitors (SSRIs) and its role in skeletal metabolism.
Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men.
TLDR
BMD was lower among those reporting current SSRI use, but not among users of other antidepressants, similar to that seen with glucocorticoids.
The serotonin signaling system: from basic understanding to drug development for functional GI disorders.
TLDR
The initial success encountered with serotonergic agents holds promise for newer and more potent insights and therapies of brain-gut disorders.
Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures.
TLDR
Use of SSRIs but not TCAs is associated with an increased rate of bone loss at the hip in this cohort of older women.
...
1
2
...